New ingestible sensor for non-intrusive sleep disorder monitoring developed by MIT and collaborators

A recent Device study reported the effectiveness of an ingestible vitals-monitoring pill (VM pill) to monitor vital signs, including heart and respiratory rate based on a human trial.

Novo Nordisk to acquire heart disease-focused Cardior Pharmaceuticals in deal worth $1.1 billion

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional

March 25, 2024

How EHRs Should Help not Hurt Health System Finances – RCM

Sandra Johnson, SVP of Client Services at CliniComp Hospitals and health systems continue to face persistent challenges from rising costs and labor shortages across clinical,

July 18, 2024

Drugmakers to Maryland affordability board: Capping list prices may not help patients

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.